ALPS Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,395
Closed -$1.58M 902
2021
Q3
$1.58M Sell
6,395
-425
-6% -$121K 0.02% 344
2021
Q2
$2.83M Sell
6,820
-2,450
-26% -$971K 0.03% 229
2021
Q1
$3.62M Buy
9,270
+29
+0.3% +$14.3K 0.04% 191
2020
Q4
$5.18M Buy
+9,241
New +$5.86M 0.06% 174
2020
Q2
Sell
-7,746
Closed -$4.61M 784
2020
Q1
$4.61M Sell
7,746
-864
-10% -$842K 0.07% 149
2019
Q4
$9.79M Buy
+8,610
New +$9.36M 0.08% 116
2018
Q2
Sell
-122
Closed -$270K 933
2018
Q1
$270K Buy
+122
New +$310K ﹤0.01% 824
2017
Q4
Sell
-3,466
Closed -$6.17M 848
2017
Q3
$6.17M Buy
3,466
+613
+21% +$856K 0.04% 133
2017
Q2
$3.88M Buy
2,853
+140
+5% +$169K 0.03% 152
2017
Q1
$3.19M Sell
2,713
-55
-2% -$56.1K 0.02% 157
2016
Q4
$2.21M Sell
2,768
-890
-24% -$707K 0.02% 175
2016
Q3
$3.21M Sell
3,658
-349
-9% -$253K 0.03% 162
2016
Q2
$2.25M Buy
4,007
+801
+25% +$454K 0.02% 162
2016
Q1
$1.76M Sell
3,206
-524
-14% -$322K 0.02% 159
2015
Q4
$3.1M Buy
+3,730
New +$3.73M 0.03% 148
2015
Q2
Sell
-1,249
Closed -$1.95M 682
2015
Q1
$1.95M Buy
+1,249
New +$1.65M 0.02% 149

Other funds holding BLUE

ALPS Advisors's BLUE Position: Q4 2021 in Review

ALPS Advisors sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 6,395 shares — an estimated $1.58M sold.

ALPS Advisors first reported a position in BLUE in Q1 2015 and held it in 16 quarters. The position peaked at $9.79M in Q4 2019. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • ALPS Advisors reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • ALPS Advisors sold 6,395 bluebird bio shares in Q4 2021, an estimated $1.58M.
  • ALPS Advisors first reported a position in bluebird bio in Q1 2015 and held it in 16 quarters.
  • ALPS Advisors's bluebird bio position peaked at $9.79M in Q4 2019.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.